➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Johnson and Johnson
McKesson
Mallinckrodt
Colorcon

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

CHLORPHENIRAMINE MALEATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Chlorpheniramine Maleate patents expire, and what generic alternatives are available?

Chlorpheniramine Maleate is a drug marketed by Aurolife Pharma Llc, Bel Mar, Elkins Sinn, Watson Labs, Pharm Assoc, Avanthi Inc, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, and West Ward. and is included in thirty NDAs.

The generic ingredient in CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.

US ANDA Litigation and Generic Entry Outlook for Chlorpheniramine Maleate

A generic version of CHLORPHENIRAMINE MALEATE was approved as chlorpheniramine maleate by AVANTHI INC on May 13th, 2009.

  Start Trial

Drug patent expirations by year for CHLORPHENIRAMINE MALEATE
Drug Prices for CHLORPHENIRAMINE MALEATE

See drug prices for CHLORPHENIRAMINE MALEATE

Drug Sales Revenue Trends for CHLORPHENIRAMINE MALEATE

See drug sales revenues for CHLORPHENIRAMINE MALEATE

Recent Clinical Trials for CHLORPHENIRAMINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sephoris Pharmaceuticals LLCPhase 2
Sino-American Tianjin Smith Kline & French Laboratories LtdPhase 4
GlaxoSmithKlinePhase 4

See all CHLORPHENIRAMINE MALEATE clinical trials

Medical Subject Heading (MeSH) Categories for CHLORPHENIRAMINE MALEATE

US Patents and Regulatory Information for CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080791-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 085139-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc CHLORPHENIRAMINE MALEATE chlorpheniramine maleate CAPSULE, EXTENDED RELEASE;ORAL 070797-001 Aug 12, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Panray CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 083243-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Roxane CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080626-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Moodys
Harvard Business School
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.